Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy-Reference-Cited by-同舟云学术

Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy

Published:2016-10 Issue:10 Volume:33 Page:685-697
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Liu Jing,Yang Bin,Ke Jun,Li Wenjia,Suen Wen-Chen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-016-0406-x.pdf

Reference112 articles.

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s Dement J Alzheimer’s Assoc. 2007;3:186–91.

2. Alzheimer’s disease—global drug forecast and market analysis to 2023. GlobalData PharmaPoint. Reference code: GDHC010EPIDR. Publication data: May 2015.

3. Geldmacher DS. Treatment guidelines for Alzheimer’s disease: redefining perceptions in primary care. Prim Care Companion J Clin Psychiatry. 2007;9:113–21.

4. Pozueta J, Lefort R, Shelanski ML. Synaptic changes in Alzheimer’s disease and its models. Neuroscience. 2013;251:51–65.

5. Hane F, Tran G, Attwood SJ, Leonenko Z. Cu(2+) affects amyloid-beta (1–42) aggregation by increasing peptide-peptide binding forces. PLoS One. 2013;8:e59005.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agmatine as a Promising Neuroprotective Strategy for Treating Neurological Disorders;International Journal of Pharmaceutical Investigation;2024-07-01

2. Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease;European Journal of Neuroscience;2024-04-15

3. AbDPP: Target‐oriented antibody design with pretraining and prior biological structure knowledge;Proteins: Structure, Function, and Bioinformatics;2024-03-05

4. Acrolein adducts and responding autoantibodies correlate with metabolic disturbance in Alzheimer’s disease;Alzheimer's Research & Therapy;2023-06-22

5. Phyllodulcin improves hippocampal long-term potentiation in 5XFAD mice;Biomedicine & Pharmacotherapy;2023-05